Kiromic Biopharma, Inc. Capital Expenditures
Kiromic Biopharma, Inc. reported Capital Expenditures of $366.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-02-14
- Kiromic Biopharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $28.00K, a 74.31% decline year-over-year.
- Kiromic Biopharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $219.00K, a 123.47% increase year-over-year.
- Kiromic Biopharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-06-30 was $98.00K.
- Kiromic Biopharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-03-31 was $21.00K.
- Kiromic Biopharma, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $366.00K, a 76.81% increase from fiscal 2023.
- Kiromic Biopharma, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $207.00K, a 95.76% decline from fiscal 2022.
- Kiromic Biopharma, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $4.88M, a 157.57% increase from fiscal 2021.
- Kiromic Biopharma, Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $1.89M, a 29.99% increase from fiscal 2020.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $247.00K derived: sum of 2 quarters · filed 2025-02-14 | $345.00K derived: sum of 3 quarters · filed 2025-02-14 | $366.00K 10-K · filed 2025-02-14 | ||
| 2024-09-30 | $219.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $317.00K derived: sum of 2 quarters · filed 2024-11-08 | $338.00K 10-Q · filed 2024-11-08 | $447.00K derived: sum of 4 quarters · filed 2025-02-14 | ||
| 2024-06-30 | $98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $119.00K 10-Q · filed 2024-08-09 | $228.00K derived: sum of 3 quarters · filed 2025-02-14 | $326.00K derived: sum of 4 quarters · filed 2025-02-14 | ||
| 2024-03-31 | $21.00K 10-Q · filed 2024-05-10 | $130.00K derived: sum of 2 quarters · filed 2025-02-14 | $228.00K derived: sum of 3 quarters · filed 2025-02-14 | |||
| 2023-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $207.00K derived: sum of 2 quarters · filed 2025-02-14 | $207.00K 10-K · filed 2025-02-14 | $206.60K 10-K · filed 2024-03-19 | ||
| 2023-09-30 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $98.00K 10-Q · filed 2024-11-08 | $97.50K 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | |||||
| 2022-12-31 | $57.20K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$75.20K derived: sum of 2 quarters · filed 2024-03-19 | $2.40M derived: sum of 3 quarters · filed 2024-03-19 | $4.88M 10-K · filed 2024-03-19 | ||
| 2022-09-30 | -$132.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $2.34M derived: sum of 2 quarters · filed 2023-11-14 | $4.82M 10-Q · filed 2023-11-14 | $5.92M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $2.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $4.96M 10-Q · filed 2023-08-14 | $6.05M derived: sum of 3 quarters · filed 2023-08-14 | $6.26M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $2.48M 10-Q · filed 2023-05-15 | $3.58M derived: sum of 2 quarters · filed 2023-05-15 | $3.79M derived: sum of 3 quarters · filed 2023-05-15 | $4.33M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $1.30M derived: sum of 2 quarters · filed 2023-04-17 | $1.85M derived: sum of 3 quarters · filed 2023-04-17 | $1.89M 10-K · filed 2023-04-17 | ||
| 2021-09-30 | $206.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $752.80K derived: sum of 2 quarters · filed 2022-11-14 | $797.50K 10-Q · filed 2022-11-14 | $1.24M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $545.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $590.60K 10-Q · filed 2022-08-12 | $1.04M derived: sum of 3 quarters · filed 2022-08-12 | $1.29M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | $44.70K 10-Q · filed 2022-05-13 | $489.20K derived: sum of 2 quarters · filed 2022-05-13 | $740.00K derived: sum of 3 quarters · filed 2022-05-13 | $1.10M derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $444.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $695.30K derived: sum of 2 quarters · filed 2022-04-08 | $1.05M derived: sum of 3 quarters · filed 2022-04-08 | $1.46M 10-K · filed 2022-04-08 | ||
| 2020-09-30 | $250.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-11 | $606.80K derived: sum of 2 quarters · filed 2022-03-11 | $1.01M 10-Q · filed 2022-03-11 | $1.29M derived: sum of 4 quarters · filed 2022-03-11 | ||
| 2020-06-30 | $356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $762.30K 10-Q · filed 2021-08-13 | $1.04M derived: sum of 3 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $406.30K 10-Q · filed 2021-05-14 | $682.50K derived: sum of 2 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $276.20K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $302.70K 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $26.50K 10-Q · filed 2020-11-30 |